• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多策略协同纳米系统重塑肿瘤血管以增强药物渗透

Reshaping Tumor Blood Vessels to Enhance Drug Penetration with a Multistrategy Synergistic Nanosystem.

机构信息

Department of Pharmacy, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou 450007, China.

School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.

出版信息

Mol Pharm. 2020 Sep 8;17(9):3151-3164. doi: 10.1021/acs.molpharmaceut.0c00077. Epub 2020 Aug 24.

DOI:10.1021/acs.molpharmaceut.0c00077
PMID:32787273
Abstract

Due to the abnormal tumor vasculature and dense stroma, there is limited tumor perfusion in the immunosuppressive tumor microenvironment (TME). In order to reshape tumor blood vessels and enhance the penetration of anticancer drugs into the tumor tissue, an anionic liposome nanosystem with a "sandwich" structure was prepared. The chemotherapeutic agent topotecan (TPT) was encapsulated in the lipid hydrophilic layer, and the sensitizer indocyanine green (ICG) was loaded into the hydrophobic layer. In addition, the positively charged vascular normalization drug erlotinib (ERL) was adsorbed to the outermost layer of the microenvironment. The nanosystem showed superior tumor permeability / experiments compared with the ERL-treated group. The nanosystem entered the tumor through normalization of blood vessels after the action of ERL. Ultrasound treatment improves the vascular permeability, allowing the nanoparticles to penetrate blood vessels and reach tumor cells. Finally, in addition to cytotoxic effects, TPT can also down-regulate the expression of HIF-1α and so prolong the vascular normalization time. These experimental results showed that the nanosystem effectively improves the tumor microenvironment. This work indicates the great potential of vascular normalization combined with sonodynamic therapy and chemotherapy to enhance efficiency.

摘要

由于肿瘤血管异常和基质致密,肿瘤在免疫抑制的肿瘤微环境(TME)中的灌注有限。为了重塑肿瘤血管并增强抗癌药物渗透到肿瘤组织中,制备了一种具有“三明治”结构的阴离子脂质体纳米系统。化疗药物拓扑替康(TPT)被包裹在脂质亲水层中,敏化剂吲哚菁绿(ICG)被装载在疏水性层中。此外,带正电荷的血管正常化药物厄洛替尼(ERL)被吸附到微环境的最外层。与 ERL 处理组相比,纳米系统显示出优异的肿瘤通透性/实验。纳米系统在 ERL 的作用下通过血管正常化进入肿瘤。超声处理可提高血管通透性,使纳米颗粒穿透血管并到达肿瘤细胞。最后,除了细胞毒性作用外,TPT 还可以下调 HIF-1α 的表达,从而延长血管正常化时间。这些实验结果表明,纳米系统有效地改善了肿瘤微环境。这项工作表明,血管正常化联合声动力学疗法和化疗具有提高效率的巨大潜力。

相似文献

1
Reshaping Tumor Blood Vessels to Enhance Drug Penetration with a Multistrategy Synergistic Nanosystem.多策略协同纳米系统重塑肿瘤血管以增强药物渗透
Mol Pharm. 2020 Sep 8;17(9):3151-3164. doi: 10.1021/acs.molpharmaceut.0c00077. Epub 2020 Aug 24.
2
Mild Acid-Responsive "Nanoenzyme Capsule" Remodeling of the Tumor Microenvironment to Increase Tumor Penetration.轻度酸响应型“纳米酶胶囊”重塑肿瘤微环境以增加肿瘤穿透性。
ACS Appl Mater Interfaces. 2020 May 6;12(18):20214-20227. doi: 10.1021/acsami.0c03022. Epub 2020 Apr 22.
3
Physicochemical characterization and biological evaluation of amorphous solid dispersions of an anticancerous drug: Erlotinib HCl.一种抗癌药物盐酸厄洛替尼无定形固体分散体的物理化学表征及生物学评价
Sci Rep. 2025 Jul 3;15(1):23787. doi: 10.1038/s41598-025-07692-1.
4
Co-delivery of axitinib and PD-L1 siRNA for the synergism of vascular normalization and immune checkpoint inhibition to boost anticancer immunity.阿昔替尼与程序性死亡受体配体1(PD-L1)小干扰RNA(siRNA)共递送,以实现血管正常化与免疫检查点抑制的协同作用,增强抗癌免疫力。
J Nanobiotechnology. 2025 Mar 10;23(1):194. doi: 10.1186/s12951-025-03170-y.
5
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
7
Carrier-Free Nanomedicine Based on Celastrol and Methotrexate for Synergistic Treatment of Breast Cancer via Folate Targeting.基于雷公藤红素和甲氨蝶呤的无载体纳米药物通过叶酸靶向协同治疗乳腺癌
Int J Nanomedicine. 2025 Jun 27;20:8291-8304. doi: 10.2147/IJN.S516921. eCollection 2025.
8
Transforming "cold" tumors into "hot" ones immunogenic cell death by bufadienolides for reverse immunosuppressive TME in HCC.通过蟾毒配基将“冷”肿瘤转化为“热”肿瘤,实现肝癌中免疫抑制性肿瘤微环境的逆转免疫原性细胞死亡。
J Mater Chem B. 2025 Jun 25;13(25):7401-7414. doi: 10.1039/d5tb00305a.
9
Biofunctionalized polymeric nanoparticles for the enhanced delivery of erlotinib in cancer therapy.用于在癌症治疗中增强厄洛替尼递送的生物功能化聚合物纳米颗粒。
J Biomater Sci Polym Ed. 2025 May;36(7):817-842. doi: 10.1080/09205063.2024.2429328. Epub 2024 Nov 23.
10
First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.晚期表皮生长因子受体(EGFR)突变阳性非鳞状非小细胞肺癌的一线治疗
Cochrane Database Syst Rev. 2016 May 25(5):CD010383. doi: 10.1002/14651858.CD010383.pub2.

引用本文的文献

1
Amelioration of breast cancer therapies through normalization of tumor vessels and microenvironment: paradigm shift to improve drug perfusion and nanocarrier permeation.通过肿瘤血管和微环境正常化改善乳腺癌治疗:改善药物灌注和纳米载体渗透的范式转变
Drug Deliv Transl Res. 2025 Feb;15(2):389-406. doi: 10.1007/s13346-024-01669-9. Epub 2024 Jul 15.
2
Induced Vascular Normalization-Can One Force Tumors to Surrender to a Better Microenvironment?诱导血管正常化——能否迫使肿瘤向更好的微环境屈服?
Pharmaceutics. 2023 Jul 26;15(8):2022. doi: 10.3390/pharmaceutics15082022.
3
Nanomaterial-Based Antivascular Therapy in the Multimodal Treatment of Cancer.
基于纳米材料的抗血管生成疗法在癌症多模态治疗中的应用
Pharmaceutics. 2023 Apr 11;15(4):1207. doi: 10.3390/pharmaceutics15041207.
4
The involvement of PDIA2 gene in the progression of renal cell carcinoma is potentially through regulation of JNK signaling pathway.PDIA2 基因在肾细胞癌进展中的作用可能是通过调节 JNK 信号通路。
Clin Transl Oncol. 2023 Oct;25(10):2938-2949. doi: 10.1007/s12094-023-03158-w. Epub 2023 Apr 5.
5
Insights into Lipid-Based Delivery Nanosystems of Protein-Tyrosine Kinase Inhibitors for Cancer Therapy.基于脂质的蛋白酪氨酸激酶抑制剂递送纳米系统用于癌症治疗的见解。
Pharmaceutics. 2022 Dec 3;14(12):2706. doi: 10.3390/pharmaceutics14122706.
6
Co-Targeting Tumor Angiogenesis and Immunosuppressive Tumor Microenvironment: A Perspective in Ethnopharmacology.共同靶向肿瘤血管生成与免疫抑制性肿瘤微环境:民族药理学视角
Front Pharmacol. 2022 Jun 15;13:886198. doi: 10.3389/fphar.2022.886198. eCollection 2022.
7
Recent advances of nanotechnology-based tumor vessel-targeting strategies.基于纳米技术的肿瘤血管靶向策略的最新进展。
J Nanobiotechnology. 2021 Dec 20;19(1):435. doi: 10.1186/s12951-021-01190-y.
8
Multifunctional Mitochondria-Targeting Nanosystems for Enhanced Anticancer Efficacy.用于增强抗癌疗效的多功能线粒体靶向纳米系统
Front Bioeng Biotechnol. 2021 Nov 24;9:786621. doi: 10.3389/fbioe.2021.786621. eCollection 2021.